- Home
- Publications
- Publication Search
- Publication Details
Title
Fulvestrant
Authors
Keywords
-
Journal
DRUGS
Volume 71, Issue 3, Pages 363-380
Publisher
Springer Nature
Online
2011-02-15
DOI
10.2165/11204810-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1)
- (2010) S. Ohno et al. ANNALS OF ONCOLOGY
- Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
- (2010) Kathleen I. Pritchard et al. BREAST CANCER RESEARCH AND TREATMENT
- Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patients
- (2010) Mathias Warm et al. BREAST CANCER RESEARCH AND TREATMENT
- Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial
- (2010) Binghe Xu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205
- (2009) T. Li et al. ANNALS OF ONCOLOGY
- Bone turnover markers in postmenopausal breast cancer treated with fulvestrant – A pilot study
- (2009) A. Agrawal et al. BREAST
- Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
- (2009) Michael Patrick Lux et al. BREAST CANCER RESEARCH AND TREATMENT
- Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor α to vinblastine and vinorelbine
- (2009) Meihua Sui et al. BREAST CANCER RESEARCH AND TREATMENT
- Exemestane
- (2009) Emma D. Deeks et al. DRUGS
- Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study
- (2009) John F.R. Robertson et al. JOURNAL OF CLINICAL ONCOLOGY
- Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review
- (2008) Jennifer Flemming et al. BREAST CANCER RESEARCH AND TREATMENT
- Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer
- (2008) D A Cameron et al. BRITISH JOURNAL OF CANCER
- Genome-Wide Analysis of Aromatase Inhibitor-Resistant, Tamoxifen-Resistant, and Long-Term Estrogen-Deprived Cells Reveals a Role for Estrogen Receptor
- (2008) S. Masri et al. CANCER RESEARCH
- Combining Fulvestrant (Faslodex™) with Continued Oestrogen Suppression in Endocrine-sensitive Advanced Breast Cancer: the SoFEA Trial
- (2008) D. Dodwell et al. CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started